Highly Selective PPAR alpha (Peroxisome Proliferator-Activated Receptor alpha) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging Article

Iwata, Hiroshi, Osborn, Eric A, Ughi, Giovanni J et al. (2021). Highly Selective PPAR alpha (Peroxisome Proliferator-Activated Receptor alpha) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging . 10(20), 10.1161/JAHA.121.020834

Open Access International Collaboration

cited authors

  • Iwata, Hiroshi; Osborn, Eric A; Ughi, Giovanni J; Murakami, Kentaro; Goettsch, Claudia; Hutcheson, Joshua D; Mauskapf, Adam; Mattson, Peter C; Libby, Peter; Singh, Sasha A; Matamalas, Joan; Aikawa, Elena; Tearney, Guillermo J; Aikawa, Masanori; Jaffer, Farouc A

sustainable development goals

authors

publication date

  • October 19, 2021

webpage

keywords

  • ATHEROSCLEROSIS
  • BARE-METAL
  • CORONARY ANGIOPLASTY
  • CYSTEINE PROTEASE
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • DOUBLE-BLIND
  • Life Sciences & Biomedicine
  • MODULATOR SPPARM-ALPHA
  • OPTICAL COHERENCE TOMOGRAPHY
  • PACLITAXEL-ELUTING STENTS
  • SMOOTH-MUSCLE-CELLS
  • SPPARM alpha (selective peroxisome proliferator-activated receptor alpha modulator alpha)
  • Science & Technology
  • VASCULAR INFLAMMATION
  • coronary artery disease
  • inflammation
  • molecular imaging
  • optical coherence tomography
  • pemafibrate
  • restenosis

Digital Object Identifier (DOI)

publisher

  • WILEY

volume

  • 10

issue

  • 20